Effect of individual conjugate dose on immunogenicity of type 6B pneumococcal polysaccharide-N. meningitidis outer membrane protein complex conjugate vaccines in infant rhesus monkeys

Vaccine

Volumn 18, Issue 25, 2000, Pages 2808-2816

  McNeely, Tessie B ^a   Liu, Xu ^a   Bringman, Timothy ^a   Donnelly, John J ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Infectious Immunity Bacteria; Nonhuman primate; Vaccination

Indexed keywords

BACTERIAL VACCINE; CARRIER PROTEIN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; OUTER MEMBRANE PROTEIN; PNEUMOCOCCUS POLYSACCHARIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; BACTEREMIA; BACTERIAL MENINGITIS; BACTERIAL PNEUMONIA; CONJUGATE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOGENICITY; NEISSERIA MENINGITIDIS; NEWBORN; NONHUMAN; OPSONIZATION; PHAGOCYTOSIS; PRIORITY JOURNAL; RHESUS MONKEY; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

EID: 0034659610     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(00)00082-7     Document Type: Article

References (35)

1. Stool S.E., Field M.J. The impact of otitis media. Pediatr. Infect. Dis. J. 8:1989;S11-S14.
2. Hilleman M.R., McLean A.A., Vella P.P., Weibel R.E., Woodhour A.F. Polyvalent pneumococcal polysaccharide vaccines. Bull. WHO. 56:1978;371-375.
3. Vella P.P., Marburg S., Staub J.M., Kniskern P.J., Miller W., Hagopian A., Ip C., Tolman R.L., Rusk C.M., Chupak L.S., Ellis R.W. Immunogenicity of conjugate vaccines consisting of pneumococcal capsular polysaccharide types 6B, 14, 19F, and 23F and a meningococcal outer membrane protein complex. Infect. Immun. 60:1992;4977-4983.
4. Bolan G.C., Broome V., Facklam R.R., Plikaytis B.D., Fraser B.D., Schlech W.F. Pneumococcal vaccine efficacy in selected populations in the United States. Ann. Intern. Med. 104:1986;1-6.
5. Borgono J.M., McLean A.A., Vella P.P., Woodhour A.F., Canepa I., Davidson W.L., Hilleman M.R. Vaccination and revaccination with polyvalent pneumococcal polysaccharide vaccines in adults and infants. Proc. Soc. Exp. Biol. Med. 157:1978;148-154.
6. Smit P.D., Oberholzer D., Hayden-Smith S., Koornhof H.J., Hilleman M.R. Protective efficacy of pneumococcal polysaccharide vaccines. JAMA. 238:1977;2613-2616.
7. Sell S.H., Wright P.F., Vaughn W.K., Thompson J., Schiffman G. Clinical studies of pneumococcal vaccines in infants. I. Reactogenicity and immunogenicity of two polyvalent polysaccharide vaccines. Rev. Infect. Dis. 3:1981;S97-S107.
8. Black S.B., Shinefield H.R., Fireman B., Hiatt R., Polen M., Vittinghoff E. Efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine in a United States population of 61,080 children. Pediatr. Infect. Dis. J. 10:1991;97-104.
9. Anderson E.L., Kennedy D.J., Geldmacher K.M., Donnelly J.J., Mendelman P.M. Immunogenicity of heptavalent pneumococcal conjugate vaccine in infants. J. Pediatr. 128:1997;649-653.
10. Dagan R., Melamed R., Zamir O., Leroy O. Safety and immunogenicity of tetravalent pneumococcal vaccines containing 6B, 14, 19F and 23F polysaccharides conjugated to eother tetanus toxoid or diphtheria toxoid in young infants and their boosterability by native polysaccharide antigens. Pediatr. Inf. Dis. J. 16:1997;1053-1059.
11. Jonsdottir I., Sigurdardottir S.T., Vidarsson G., Ingolfsdottir G., Gudnason T., Davidsdottir K., Kjartansson S., Kristinsson K.G., Leroy O. Functional activity of antibodies elicited by octavalent pneumococcal polysaccharide conjugate vaccines, PncT and PncD. Program and Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. Toronto, American Society for Microbiology, Washington, DC. 1997;209. abstr. G-90.
12. Kayhty H., Ahman H., Ronnberg P.-R., Tillikainen R., Eskola J. Pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine is immunogenic in infants and children. J. Infect. Dis. 172:1995;1273-1278.
13. McNeely T.B., Arena D.E., Kniskern P.J., Liu M.A., Donnelly J.J., Blum M.D. Opsonic antibody responses to a three dose Pn-OMPC conjugate vaccination with a fourth dose boost of Pn-OMPC conjugate or PNEUMOVAX 23. Program and Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. Toronto, American Society for Microbiology, Washington, DC. 1997;209. abstr. G-89.
14. Dagan R., Muallem M., Melamed R., Leroy O., Yagupsky P. Reduction of pneumococcal nasopharyngeal carriage in early infancy after immunization with tetravalent pneumococcal vaccines conjugated to either tetanus toxoid or diphtheria toxoid. Pediatr. Inf. Dis. J. 16:1997;1060-1064.
15. Kristinsson K.G., Sigurdardottir S.T., Gudnason T., Kjartansson S., Davidsdottir K., Leroy O., Jonsdottir I. Effect of vaccination with octavalent protein conjugated pneumococcal vaccines on pneumococcal carriage in infants. Program and Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. Toronto, American Society for Microbiology, Washington, DC. 1997;193. abstr. G-5.
16. Marburg S., Jorn D., Tolman R.L., Arison B., McCauley J., Kniskern P.J., Hagopian A., Vella P.P. Bimolecular chemistry of macromolecules: Synthesis of bacterial polysaccharide conjugates with Neisseria meningitidis membrane protein. J. Am. Chem. Soc. 108:1986;5282.
17. Gray B.M., Dillon H.C. Clinical and epidemiological studies of pneumococcal infection in children. Pediatr. Infect. Dis. J. 5:1986;201-207.
18. Klein J.O. The epidemiology of pneumococcal disease in infants and children. Rev. Infect. Dis. 3:1981;246-253.
19. Klugman K.P. Pneumococcal resistance to antibiotics. Clin. Microbiol. Rev. 3:1990;171-196.
20. Breiman R.F., Butler J., Tenover F., et al. Emergence of drug-resistant pneumococcal infections in the United States. JAMA. 23:1994;1831-1835.
21. 197. Infect. Immun. 39:1983;233-238.
22. Schneerson R., Robbins J.B., Chu C., Sutton A., Vann W., Vickers J.C., London W.T., Curfman B., Hardegree M.C., Shiloach J., Rastogi S.C. Serum antibody responses of juvenile and infant rhesus monkeys injected with haemophilus influenzae type b and pneumococcus type 6A capsular polysaccharide-protein conjugates. Infect. Immun. 45:1984;582-591.
23. Vella P.P., Staub J.M., Armstrong J., Dolan K.T., Rusk C.M., Szymanski S., Greer W.E., Marburg S., Kniskern P.J., Schofield T.L., Tolman R.L., Hartner F., Pan S.H., Gerety R.J., Ellis R.W. Immunogenicity of a new Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) (PedvaxHIB). Pediatrics. 85:(Suppl.):1990;668-675.
24. Butler J.C., Breiman R.F., Lipman H.B., Hofmann J., Facklam R.R. Serotype distribution of Streptococcus pneumoniae infections among preschool children in the United States, 1978-1994: implications for development of a conjugate vaccine. J. Infect. Dis. 171:1995;885-889.
25. Donnelly J.J., Deck R.R., Liu M.A. Immunogenicity of a Haemophilus influenzae polysaccharide-Neisseria meningitidis outer membrane protein complex conjugate vaccine. J. Immun. 145:1990;3071-3079.
26. Liu M.A., Friedman A., Oliff A.I., Tai A.I., Martinez D., Deck R.R., Sheih J.T.C., Jenkins T.D., Donnelly J.J., Hawe L.A. A vaccine carrier derived from Neisseria meningitidis with mitogenic activity for lymphocytes. Proc. Natl. Acad. Sci. USA. 89:1992;4633-4637.
27. Rodriguez M.E., van den Dobbelsteen G.P.J.M., Oomen L.A., de Weers O., van Buren L., Beurretx L., Poolman J.T., Hoogerhout P. Immunogenicity of Streptococcus pneumoniae type 6B and 14 polysaccharide-tetanus toxoid conjugates and the effect of uncoupled polysaccharide on the antigen-specific immune response. Vaccine. 16:1998;1941-1949.
28. Howard J.G., Christie G.H., Courtenay B.M. Treadmill neutralization of antibody and central inhibition. Transplantation. 10:1970;351-353.
29. Dong ZM, Murphey JW. Effects of the two varieties of Cryptococcus neoformans cells and culture filtrate antigens on neutrophil locomotion. Infect Immun 63:2632-44.
30. Griffioen A.W., Rijkers G.T., Toebes E.A.H., Zegers B.J.M. The human in vitro anti-type 4 pneumococcal polysaccharide antibody response is regulated by suppressor T cells. Scand. J. Immun. 34:1991;229-236.
31. Heilmann C. Vaccination-induced activation of human blood T cells suppressing pneumococcal polysaccharide-specific B cells. Acta. Path. Microbiol. Immun. Scand. Sect. C. 95:1987;65-69.
32. Peeters C.C.A.M., Tenbergen-Meekes A.M., Haagmans B., Evenberg D., Poolman J.T., Zegers B.J.M., Rijkers G.T. Pneumococcal conjugate vaccines. Immun. Lett. 30:1991;267-274.
33. Dagan R., Eskola J., Leclerc C., Leroy O. Reduced response to multiple vaccines sharing common protein epitopes that are administered simultaneously to infants. Infect. Immun. 66:1998;2093-2098.
34. Peeters C.C.A.M., Tenbergen-Meekes A.-M., Poolman J.T., Zegers B.J.M., Rijkers G.T. Immunogenicity of a Streptococcus pneumoniae type 4 polysaccharide-protein conjugate vaccine is decreased by admixture of high doses of free saccharide. Vaccine. 12:1992;833-840.
35. MacDonald N.E., Halperin S.A., Law B.J., Forrest B., Danzig L.E., Granoff D.M. Induction of immunologic memory by conjugated vs. plain meningococcal C polysaccharide vaccine in toddlers. JAMA. 280:1998;1685-1689.